MentionFox
Home › Layoffs › Allogene Therapeutics, Inc.
SEC filings · Form 8-K, Item 2.05

Allogene Therapeutics, Inc. layoffs and restructuring

Before you join, sell to or invest in Allogene Therapeutics, Inc.

MentionFox check on Allogene Therapeutics, Inc.: only 1 source on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/layoffs/allogene-therapeutics

  • Note: Layoff plan disclosed Jan 2024 (filing)

New since last check: Layoff plan disclosed Jan 2024 (filing, first seen 14 November 2026).

Check Allogene Therapeutics, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Allogene Therapeutics, Inc.?

Every exit or restructuring plan Allogene Therapeutics, Inc. reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

Allogene Therapeutics, Inc.'s latest layoff filing, on January 5, 2024, states a cut of about 22% of its workforce. As of November 14, 2026, it has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, January 5, 2024).

10 companies announced layoffs this week, 1 had other signals.

Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.

UPWORK, INCannounced layoffs
PVH CORP. /DE/announced layoffs
Battellefiled a layoff notice for 15 employees
TidalHealth Primary Carefiled a layoff notice for 5 employees
Phunware, Inc.announced layoffs
Check one company free All companies that announced layoffs this week

Pfizer Inc. also filed stake reports on 4 other companies ↓

Is this your company?

Owed money by them or selling to them? See the free Snapshot of Allogene Therapeutics, Inc.

Free to see. No signup.

People from Allogene Therapeutics, Inc. who say they are open to work

Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.

Loading the list…

Affected by the Allogene Therapeutics, Inc. layoff? Add yourself to the open-to-work list, free
SEC filings1
Latest filing2024-01-05

Allogene Therapeutics, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

Did Allogene Therapeutics have layoffs in 2024? What its filings say

Allogene Therapeutics, Inc. (CIK 1737287) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K filed 2024-01-05

Share of workforce

On January 4, 2024, the Company's Board of Directors approved a reduction in the Company's workforce of approximately 22% of the Company's employees in connection with the Company's pipeline prioritization and clinical development strategy.

Expected charges

The Company estimates that it will incur charges of approximately $5.0 million to $5.5 million for severance payments and employee benefits, primarily in the first quarter of 2024.

Timing

The reduction in workforce is expected to be substantially completed by the end of January 2024.

Also on the record for Allogene Therapeutics, Inc.

DateRecordFigureOur pageSource
November 10, 2026Stake report, Schedule 13G, by STATE STREET CORPORATION4.7% of the class5%+ stakesSource
October 27, 2026Stake report, Schedule 13G/A, by BlackRock, Inc.6.7% of the class5%+ stakesSource
September 30, 2026Stake report, Schedule 13D/A, by TPG GP A, LLC—5%+ stakesSource
September 2, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
August 14, 2026Stake report, Schedule 13G/A, by Frazier Life Sciences Public Fund, L.P.5.6% of the class5%+ stakesSource
August 7, 2026Stake report, Schedule 13G, by STATE STREET CORPORATION5.5% of the class5%+ stakesSource
August 7, 2026Stake report, Schedule 13G/A, by Arie Belldegrun, M.D.3.9% of the class5%+ stakesSource
May 28, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
May 15, 2026Stake report, Schedule 13G/A, by Kenneth Griffin2.8% of the class5%+ stakesSource
May 15, 2026Stake report, Schedule 13G/A, by Lynx1 Capital Management LP—5%+ stakesSource
May 13, 2026Stake report, Schedule 13G/A, by Arie Belldegrun, M.D.5.4% of the class5%+ stakesSource
May 13, 2026Stake report, Schedule 13G/A, by David D. Chang, M.D., Ph.D.4.9% of the class5%+ stakesSource

Keep reading

More on Allogene Therapeutics, Inc. and the records around it.

Allogene Therapeutics, Inc. elsewhere on the record

Companies that share a holder

What do you want to do with Allogene Therapeutics, Inc.?

Want the whole picture on Allogene Therapeutics, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Allogene Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Allogene Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    13 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 22 records.

Tools for this story

Each opens in a new tab, filled in for Allogene Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

Cite this page

Permanent URL: https://mentionfox.com/layoffs/allogene-therapeutics
Last updated 2026-11-14
Allogene Therapeutics layoffs 2024: 22% of workforce (8-K). MentionFox, 2026-11-14. https://mentionfox.com/layoffs/allogene-therapeutics